Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide

NCT05180331 is registered in ClinicalTrials.gov with Butler Hospital as lead sponsor.

NCT NCT05180331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide
Lead sponsor
Butler Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2023
Completion date
May 20, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation, suicide, suicide and self-harm, suicide, attempted